TMCnet News
UVCeed Wins Fast Company 2023 Next Big Things in Tech AwardUVCeed today announced it has won a Fast Company 2023 Next Big Things in Tech Award. The company was honored in the Wellness and Fitness category for its flagship product, the first personal AI-powered mobile UV-C disinfectant platform. Fast Company's Next Big Things In Tech Awards highlight new technology breakthroughs from around the world that will help define the future of the industries they serve. "With new COVID cases on the rise, kids back in school, and the cold and flu season looming, protecting yourself against germs is a full-time effort," said Dr. Peter Bonutti, co-founder & CEO, UVCeed. "UVCeed offers on-the-go protection against pathogens wherever you are. We are very excited to receive this Next Big Things in Tech Award for our continued efforts to ensure the health of individuals, families and communities." UVCeed, now available for both iOS and Android, is 99.99 percent effective at killing germs, bacteria and viruses, including SARS-CoV-2, the virus that causes COVID-19, in seconds. UVCeed attaches to the back of any smartphone and is outfitted with powerful mrcury-free LED UV light rays and multiple sensors, proprietary iCide smart dosage and iCide safety technology, and an intuitive app that gives users the power, visibility and confidence to protect themselves anytime, anywhere. To see how UVCeed works, watch this video. UVCeed's Next Big Things in Tech Award is the latest accolade for the company in 2023. Earlier this year, UVCeed received a TMC 2023 Pandemic Tech Innovation Award, preceded by a 2022 Mom's Choice Award honoring excellence in family-friendly media, products and services. UVCeed will showcase its award-winning innovation at CES 2024, booth 8372, North Hall, in the Las Vegas Convention Center, January 9-12, 2024. For more information on UVCeed, visit www.uvceed.com. About UVCeed UVCeed is the first personal AI-powered mobile UVC disinfectant platform for work, home, school, or travel. It is designed by Bonutti Research, a medical device incubator with a 30+ year history of innovation, over 400 patents and applications, and 700 licenses. As a practicing surgeon, Dr. Peter Bonutti understands the importance of infection control and developed UVCeed to create a convenient device for personal use that is safe and effective. UVCeed's patented technology leverages machine learning and computer vision to ensure safe usages and proper amount of energy is used to achieve the desired level of disinfection. For more information, visit https: www.uvceed.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231128884065/en/ |
